Treating COVID-19 with NRICM101 and NRICM102 - Author's reply 3
Pharmacol Res
.
2022 Nov:185:106445.
doi: 10.1016/j.phrs.2022.106445.
Epub 2022 Sep 9.
Authors
Yu-Hwei Tseng
1
,
Sunny Jui-Shan Lin
2
,
Ming-Yung Lee
3
,
Yi-Chang Su
4
Affiliations
1
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.
2
Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
3
Department of Data Science and Big Data Analytics, Providence University, Taichung, Taiwan.
4
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan. Electronic address: sychang@nricm.edu.tw.
PMID:
36096426
PMCID:
PMC9461338
DOI:
10.1016/j.phrs.2022.106445
No abstract available
Keywords:
COVID-19; NRICM101; NRICM102; Traditional Chinese Medicine.
Publication types
Letter
MeSH terms
Acupuncture Therapy*
COVID-19*
Humans
Medicine, Chinese Traditional